openPR Logo
Press release

Announcing the Launch of the Online Course: Preventing Lyme and Tick-Borne Diseases

05-25-2024 02:06 AM CET | Associations & Organizations

Press release from: Getnews

/ PR Agency: US China Brand, LLC
Announcing the Launch of the Online Course: Preventing Lyme

Image: https://www.getnews.info/uploads/e0e2241e8a8b8054c2cb0df83957d240.png

Savannah, GA - In honor of Lyme Disease Awareness Month, Alexis Chesney MS, ND, LAc, a passionate advocate for Lyme disease prevention, is proud to announce the launch of a comprehensive new online course: Preventing Lyme and Tick-Borne Diseases: Ticks from Around the World, Diseases They Carry, Prevention, and Acute Treatments . Learn more here: https://health-transformations.teachable.com/p/preventing-lyme-and-other-tick-borne-diseases.

A recent CDC report reveals that Lyme disease cases increased by 69% in 2022 compared to previous years. Lyme disease remains a significant public health challenge, with no current vaccine available, limited accuracy with conventional testing, and 10-20% of those treated for Lyme disease experiencing chronic symptoms. This course aims to bridge the knowledge gap, offering valuable insights crucial for individuals and healthcare providers alike.

Course Highlights:

- In-depth exploration of ticks from across the globe

- Detailed information on the signs and symptoms of the diseases carried by these ticks

- Practical and effective prevention techniques

- What to do if you get a tick bite

- Comprehensive acute treatment strategies for those affected by tick-borne diseases

To celebrate the launch, Dr. Chesney is offering free access to the subchapter "Ticks from Around the Globe: Introduction and North American Ticks." This section provides a foundational understanding of the subject matter and sets the stage for the comprehensive content that follows. This self-paced course is designed to provide thorough and accessible information that can be applied in everyday life, and includes over 200 journal article references to enhance the education of healthcare professionals.

"I've watched my patients get their lives back after Lyme diseaes treatment, only to see them return with a new tick bite or new tick-borne disease. As someone deeply committed to the prevention of Lyme disease, I've created this course to empower individuals with the knowledge they need to protect themselves and their loved ones. Prevention is key," said Alexis Chesney.

About Alexis Chesney, MS, ND, LAc:

Alexis Chesney is a licensed naturopathic physician, acupuncturist, author, and educator. Since 2010, Dr. Chesney has specialized in the diagnosis and treatment of Lyme and vector-borne diseases, and complex chronic illness. Dr. Chesney enjoys getting to the root cause of complex chronic illness and partnering with clients to find wellness and balance in their lives. Dr. Chesney is passionate about education and speaks at medical conferences and to the general public. She also enjoys mentoring other medical practitioners.

Find her at https://www.dralexischesney.com/.

For more information and to access the course, visit https://www.dralexischesney.com/ and https://health-transformations.teachable.com/p/preventing-lyme-and-other-tick-borne-diseases.
Media Contact
Company Name: Alexis Chesney MS, ND, LAc
Contact Person: Alexis Chesney
Email: Send Email [http://www.universalpressrelease.com/?pr=announcing-the-launch-of-the-online-course-preventing-lyme-and-tickborne-diseases]
City: Savannah
State: GA
Country: United States
Website: http://www.DrAlexisChesney.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Announcing the Launch of the Online Course: Preventing Lyme and Tick-Borne Diseases here

News-ID: 3512349 • Views:

More Releases from Getnews

Freedive Academy Expands AIDA, SSI and Molchanovs Freediving Instructor Courses with Structured Career Pathway in the Philippines
Freedive Academy Expands AIDA, SSI and Molchanovs Freediving Instructor Courses …
Panglao, Philippines - As global demand for professional freedive instructors continues to grow, Freedive Academy has expanded its multi-agency Freediving Instructor Courses under AIDA, SSI, and Molchanovs, further establishing its position as the leading instructor training hub in the industry. Founded in 2015, the Academy has trained over 250 freediving instructors and delivers approximately 25 instructor-level programs annually. Across all training levels, students from 68 countries have completed programs at Freedive
More Than Messages: Dr. Pieter Noomen's Writings Highlight the Lasting Power of the Written Word
More Than Messages: Dr. Pieter Noomen's Writings Highlight the Lasting Power of …
Image: https://www.globalnewslines.com/uploads/2026/02/e3f46560cad81e7983cbff1c2fe013d3.jpg LOS ANGELES - In a world increasingly shaped by short texts, scrolling feeds and instant replies, the late Dr. Pieter Noomen offered a different perspective on communication - one rooted in the belief that words, when written and received with intention, can reach far beyond the surface of daily life. A psychotherapist and minister known for his deeply reflective spiritual teachings, Dr. Noomen devoted much of his life to exploring
New Executive Leadership Book Challenges Companies to Prove AI ROI in 90 Days - or Reassess the Investment
New Executive Leadership Book Challenges Companies to Prove AI ROI in 90 Days - …
Image: https://www.globalnewslines.com/uploads/2026/02/d9bdbed2c267656dd755cc2010944312.jpg AI ROI or It Didn't Happen Reframes Artificial Intelligence as a Leadership Accountability Discipline, Not a Technology Experiment Artificial intelligence spending is accelerating across industries. Enterprises are deploying AI copilots, automation systems, predictive tools, and generative platforms at unprecedented speed. Boards are approving budgets. Transformation teams are expanding. Vendors are promising competitive advantage. Yet inside executive meetings, a quieter question is surfacing: Is this actually improving the business? While adoption metrics are rising,
"Wellness Unwrapped | The TFAL & CHI Journey" Now Streaming on BraveHeartsTV - N …
Image: https://www.getnews.info/uploads/1701260975.png Where medicine meets movement and mindset. Science-backed conversations that help viewers turn everyday habits into lasting health. SCHAUMBURG, IL. - Feb. 27, 2026 - BraveHeartsTV - Network announces the launch of "Wellness Unwrapped | The Tfal & Chi Journey," which premiered Feb. 13, 2026, and is now streaming across BraveHeartsTV - Network platforms, including connected TV and the web. Image: https://www.globalnewslines.com/uploads/2026/02/917da7342cc0027d4ba1cae4f4429b07.jpg Hosted by Dr. Toyin "Tfal" Falusi Nwafor, MD, and Chioma "Chi"

All 5 Releases


More Releases for Lyme

Lyme Disease Diagnostics Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Lyme Disease Diagnostics Market Insights, to 2033" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lyme Disease Diagnostics market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample
Lyme Disease - Drug Pipeline Landscape, 2022
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. To know more about Lyme Disease - Drug Pipeline ,
Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time. Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Global Lyme Disease Therapeutics Market: Overview Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes. View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html If left untreated, these symptoms may worsen and can lead to partial or complete
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs